Search
Total Count 17

JAMJOOM PHARMA - Argaam Reports

Jamjoom Pharma revises guidance for next 3 years 

Argaam Special 30/04/2025

Highest-paid executives, board members of Saudi-listed firms in 2024

Argaam Special 21/04/2025

Jamjoom Pharma Q4 2024: What are analysts predicting?

Argaam Special 30/01/2025

Analyst ratings, average TP for Jamjoom Pharma post-Q3 2024

Argaam Special 23/12/2024

Jamjoom Pharma maintains 2024 guidance

Argaam Special 27/10/2024

What do analysts expect from Jamjoom Pharma's Q3 2024 results?

Argaam Special 24/10/2024

Key events forecast to impact Saudi-listed firms’ earnings in Q3 2024

Argaam Special 06/10/2024

How analysts rated Jamjoom Pharma after Q2 results?

Argaam Special 11/09/2024

Analyst forecasts on Jamjoom Pharma Q2 2024 profit

Argaam Special 05/08/2024

Key events likely to impact Saudi-listed firms’ earnings in Q2 2024

Argaam Special 04/07/2024

Senior execs of Aramco, SNB, eXtra, stc highest paid in 2023

Argaam Special 21/04/2024

Highest-paid executives, board members of Saudi-listed firms in 2023

Argaam Special 16/04/2024

Jamjoom Pharma seen to post profit growth in Q4 2023

Argaam Special 20/02/2024

How did analysts view TASI performance, top picks for 2024?

Argaam Special 09/01/2024

How did analysts view Jamjoom Pharma’s Q3 financials?

Argaam Special 05/12/2023

TASI leaps 5.5% in 9M 2023; Etihad Atheeb, Elm top gainers

ِArgaam special 30/09/2023

Jamjoom Pharma revises up 2023 guidance

Argaam Special 10/08/2023